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 ABSTRACT 
Tapan Patel: The Longitudinal Trajectories of Internalizing Symptoms in Individuals with 
22q11.2 Deletion Syndrome 
(Under the direction of Blaise Morrison) 
 
Internalizing symptoms (i.e., anxiety, depression, withdrawal) are highly prevalent in the 
22q11.2 Deletion Syndrome (22q11DS) population. There is a need to identify how these 
symptoms change over time and to determine what factors affect the trajectory of these 
symptoms. The purpose of this research is to determine how internalizing symptoms change over 
time and how factors such as intelligence, attention, working memory, and demographics affect 
these trajectories. Due to the nature of 22q11DS, the presence of these internalizing symptoms 
further debilitates these individuals. There is a need to identify how and when interventions can 
address these symptoms. Data was analyzed using multilevel modeling. Results showed that 
internalizing trajectories improved as time progressed, and demographics had a significant effect 
while cognitive symptoms of 22q11DS had no effect on these trajectories. The implications of 
these findings are discussed. 
iv 
TABLE OF CONTENT 
LIST OF TABLES ......................................................................................................................... vi 
LIST OF FIGURES ...................................................................................................................... vii 
LIST OF ABBREVIATIONS ...................................................................................................... viii 
CHAPTER 1: INTRODUCTION ....................................................................................................1 
            Features of 22q11DS ............................................................................................................1 
                        Cognitive Features ...................................................................................................2 
                        Psychiatric Features .................................................................................................3 
                        Behavioral Features .................................................................................................4 
            Internalizing Symptoms .......................................................................................................5 
                        Impact of Internalizing Symptoms...........................................................................6 
            Trajectory of Internalizing Symptoms in individuals with 22q11DS ..................................7 
                        Factors Affecting the Trajectories of Internalizing Symptoms ................................8 
                                    Intelligence ...................................................................................................9 
                                    Attention .......................................................................................................9 
                                    Working Memory .........................................................................................9 
                                    Demographics ............................................................................................10 
            Prior Longitudinal Studies .................................................................................................10 
            Present Aims ...................................................................................................................... 11 
CHAPTER 2: METHODS .............................................................................................................14 
           
v 
            Participants .........................................................................................................................14 
            Predictor Measures.............................................................................................................14 
                        WISC ......................................................................................................................14 
                        CPT-IP/AX .............................................................................................................15 
                        Demographic Variables ..........................................................................................15 
            Outcome Measures.............................................................................................................15 
                        CBCL .....................................................................................................................15 
            Procedures ..........................................................................................................................16 
            Statistical Analysis .............................................................................................................16 
CHAPTER 3: RESULTS ...............................................................................................................18 
CHAPTER 4: DISCUSSION .........................................................................................................20 
            Implications for Rehabilitation Counselors .......................................................................21 
            Limitations .........................................................................................................................23 
            Conclusion .........................................................................................................................24 
APPENDIX 1: TABLES ................................................................................................................25 




LIST OF TABLES 
Table 1- Sample Descriptives ........................................................................................................25 
Table 2- Internalizing Symptoms Multilevel Model ......................................................................26 
Table 3- Internalizing Symptoms Multilevel Model with Constrained Time ................................27 
Table 4- Internalizing Symptoms Multilevel Model with Intelligence ..........................................28 
Table 5- Internalizing Symptoms Multilevel Model with Working Memory ................................30 
Table 6- Internalizing Symptoms Multilevel Model with Attention ..............................................32 
 
vii 
LIST OF FIGURES 
Figure 1- Internalizing symptoms trajectory by sex ......................................................................34 
Figure 2- Internalizing symptoms trajectory by ethnicity..............................................................35 
Figure 3- Internalizing symptoms trajectory by SES .....................................................................36 
Figure 4- Internalizing symptoms trajectory controlled for sex, ethnicity, and SES .....................37
 
viii 
LIST OF ABBREVIATIONS 
22q11DS  22q11.2 Deletion Syndrome  
ADHD   Attention Deficit Hyperactivity Disorder 
CBCL    Child Behavior Checklist 
CPT-IP/AX                 Continuous Performance Test Identical Pairs d-Prime and AX d-Prime 
FSIQ               Full Scale Intelligence quotient  
IQ                                Intelligence Quotient   
SES               Socioeconomic status 
WISC-IV                     Wechsler intelligence scale for children fourth version 
WMI                            Working Memory Index  
 
1 
CHAPTER 1: INTRODUCTION 
Chromosome 22q11.2 Deletion Syndrome (22q11DS) is a microdeletion syndrome that is 
characterized by a confluence of medical, psychiatric, and neurocognitive symptoms (Hooper et 
al., 2013). Individuals with 22q11DS experience many difficulties in many different life domains 
due to the features and symptoms associated with this disorder (Armando, Lin, Pontillo, & 
Vicari, 2017). One of the more common aspects of 22q11DS is the presence of internalizing 
symptoms such as anxiety, depression, and withdrawal that significantly affect multiple aspects 
of these individuals’ lives (Armando et al., 2017; Fabbro, Rizzi, Schneider, Debbane, & Eliez, 
2012).  
It is evident that there is a need to examine how these symptoms progress in this 
population and to determine what factors affect the trajectory of these symptoms. The possible 
factors that may be affecting these symptoms could be other cognitive symptoms associated with 
22q11DS (i.e., lower intelligence, poor attention, impaired working memory). Discovering how 
these symptoms progress over time and what factors predict these trajectories could help 
researchers and treatment providers create and implement targeted interventions that could slow 
and/or lessen the appearance of significant internalizing symptoms over time.  
Features of 22q11DS 
 22q11DS is one of the most prevalent microdeletion syndromes in the world with an 
approximate incidence rate of 1:2000 (Shprintzen, 2008). With a high incidence rate, it has 
become imperative to better understand 22q11DS in order to successfully intervene and help
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 these individuals live long and fulfilling lives. A wide variety of features and symptoms are 
associated with 22q11DS (Shprintzen, 2008). These features are perhaps best understood when
they are divided into categories. Three distinct dimensions that are affected by 22q11DS are 
cognition, affect, and behavior (Badoud et al., 2017; Bearden et al., 2004; Duijff et al., 2013).  
Cognitive Features 
 One of the most important cognitive aspects that is affected by 22q11DS is intelligence 
(Duijff et al., 2013). Many individuals with 22q11DS have IQ scores under 70, in many instances 
reflecting the presence of an intellectual disability (Bearden et al., 2004; Duijff et al., 2013). Due 
to the deletion of the 22nd chromosome, there is a significant impact on the development of the 
brain that contributes to the impairment in intelligence (Duijff et al., 2013). Additionally, Duijff 
et al. (2013) found that intelligence may not be stable in this population. They found that 
intelligence declines as some individuals with 22q11DS age; although, others remain relatively 
stable over time. Duijff et al. (2013) recommended for additional research to determine the 
longitudinal trajectory of intelligence in this population, with a particular focus on factors that 
might be contributory to a decline in cognitive abilities. 
 Another cognitive aspect that is affected by 22q11DS is working memory (Campbell et 
al., 2010). Campbell et al. (2010) conducted a study comparing various cognitive aspects of 
individuals with 22q11DS to their siblings without 22q11DS. They found that the participants 
with 22q11DS exhibited particular deficits in visuospatial working memory. They concluded that 
individuals with 22q11DS have difficulty identifying and remembering visual aspects of the 
environment. They suggested that their findings support the literature as a whole that individuals 
with 22q11DS have significant deficits in working memory and further research is needed to 
address these deficits (Campbell et al., 2010).  
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 Due to the impairments of intelligence and visual working memory, attention is deeply 
affected by 22q11DS (Antshel et al., 2007). Antshel et al. (2007) conducted a study to determine 
how attention deficits in the 22q11DS population differ from the deficits in individuals with 
Attention-Deficit Hyperactivity Disorder (ADHD). They found that individuals with 22q11DS 
showed significant impairments in attention that, in some cases, were worse than the idiopathic 
comparison sample. They suggested that individuals with 22q11DS have significant impairments 
in attention that need to be addressed to successfully help these individuals progress in education 
(Antshel et al., 2007). Niarchou, Martin, Thapar, Owen, and van den Bree (2015) further 
corroborated these findings and found that the presentation of ADHD may not manifest as they 
do in the idiopathic ADHD population. Though the clinical presentation is different, these 
individuals are being significantly impacted by attention issues, but they may not be receiving 
treatment for these issues (Niarchou et al., 2015). It is pertinent to further understand these 
clinical presentations in this population.  
Psychiatric Features 
 In addition to ADHD, the three most prevalent psychiatric disorders seen in the 22q11DS 
population are anxiety, depression, and schizophrenia (Jolin, Weller, & Weller, 2012; Schneider 
et al., 2014). Individual with 22q11DS often meet the full criteria for various anxiety and mood 
disorders, but due to other medical conditions associated with 22q11DS these disorders are often 
left untreated or unnoticed (Hooper et al., 2013; Jolin et al., 2012). The exact cause of these 
symptoms is unknown, but the general consensus is that these affective symptoms are related to 
the cognitive and developmental features associated with 22q11DS (Tang, Antshel, Fremont, & 
Kates, 2015). There is an undisputable need for research to determine how these features
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 manifest and progress in this population before they become disorders and before they 
potentially lead to the development of psychosis (Tang et al., 2015). 
 
 Psychotic symptoms also are prevalent in this population, with their manifestation 
occurring more frequently in late adolescents and young adulthood (Baker & Skuse, 2005). 
There is strong evidence that suggests that there may be a link between 22q11DS and the 
development of schizophrenia later in life (Tang et al., 2015). Jolin et al. (2009) found that a 
third of their sample exhibited psychotic symptoms, such as persecutory and referential 
delusions, and they suggest that these symptoms could likely develop into psychotic disorders in 
the future if they are not addressed. Similarly, Ramanathan et al. (2017) found that psychotic 
symptoms were related to cortical differences in the brain, and suggested that these individuals 
will likely develop these symptoms if earlier interventions are not implemented. It is pertinent 
that these interventions also target the behavioral features associated with 22q11DS. 
Behavioral Features  
 There are various behavioral features that are associated with 22q11DS. Some of the 
most common issues that occur are social withdrawal/isolation, impulsivity, emotional lability, 
and disinhibition (Tang et al., 2015). The causes of these behaviors are not exactly known, but 
there is evidence that the cognitive deficits associated with 22q11DS are not the sole reason for 
the behavioral problems experienced by these individuals (Duijff et al., 2013). There is evidence 
that these issues may be caused by deficits in social skills, but further study is necessary to 





 The most common internalizing symptoms in the 22q11DS population are anxiety, 
depression, social withdrawal, obsessions, and compulsions (Schneider et al., 2014; Wray, 
Shashi, Schoch, Curtiss, & Hooper, 2013). The exact causes of these symptoms are unknown, 
but the overwhelming prevalence of each of these symptoms in the 22q11DS population 
substantiates the need to better understand underlying mechanisms and to develop interventions 
to help these individuals (Armando et al., 2017). Due to the neurodevelopmental nature of 
22q11DS, many theories have suggested that the cause of these internalizing symptoms may also 
be neurodevelopmental in nature (Kelley, Sanders, Beaton, 2016; Fabbro et al., 2012; Vergaelen, 
Claes, Kempke, & Swillen, 2017).  
 One hypothesis as to why there is a high prevalence of internalizing symptoms is a 
deficiency of vitamin D (Kelley et al., 2016). Kelley et al. (2016) suggested that due to the 
neuroprotective nature of vitamin D, the deficit of this vitamin could explain the presence of 
internalizing symptoms in this population. They found that there was a negative correlation 
between vitamin D and internalizing symptoms. Due to the developmental role of vitamin D, 
they believe that the deficiency of this vitamin contributes to alterations in the development of 
the brain. They suggest that if this insufficiency can be addressed early in the development of the 
22q11DS population, internalizing feelings could be minimized (Kelley et al., 2016).  
 Another possible cause of these internalizing symptoms and affective changes could be 
fatigue (Vergaelen et al., 2017). Vergaelen et al. (2017) found that there is a high prevalence of 
excessive fatigue in individuals with 22q11DS. They believe that this fatigue could affect the 
development of the brain; subsequently, this fatigue leads to internalizing symptoms such as 
anxiety and depression. The etiology of the fatigue is unknown, but Vergaelen et al. (2017)
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suggested that if the cause of this fatigue can be made clear, targeted interventions can be created 
and implemented. They suggested that better understanding the presence of fatigue could be one 
of the key factors to minimizing the internalizing symptoms associated with 22q11DS 
(Vergaelen et al., 2017). It is pertinent to understand how internalizing symptoms impact these 
individuals.
Impact of Internalizing Symptoms in Individuals with 22q11DS 
Though the exact causes of these internalizing symptoms are unknown, the impact of 
how these symptoms affect individuals with 22q11DS has been well studied and elucidated 
(Briegel, Schneider, & Schwab, 2008; Gothelf et al., 2007; Wray et al., 2017). These symptoms 
are often debilitating in the general population, and they can be even more debilitating in the 
22q11DS population because of the other challenges these individuals face (Niarchou et al., 
2018). These symptoms significantly impact individuals in a wide variety of ways, including 
social interactions with peers, adaptive functioning, and perhaps facilitating the onset of 
psychosis and other psychiatric disorders (Armando et al., 2017; Gothelf et al., 2007; Schneider 
et al., 2014).  
One of the most heavily impacted areas of functioning in individuals with 22q11DS is 
social interaction with peers (Armando et al., 2017). Social functioning is believed to be 
impacted by the cognitive impairments associated with this genetic connection, but there is also a 
possibility that internalizing symptoms affect psychosocial functioning as well (Armando et al., 
2017; Kikinis et al., 2017; Schneider, Van der Linden, Menghetti, Debbané, & Eliez, 2017). 
Armando et al. (2017) explored how psychiatric symptoms affect individuals with 22q11DS. 
They found that anxiety was positively correlated to impairment in social functioning. They 
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suggest that early intervention targeting anxiety may lead to better psychosocial outcomes as 
these individuals develop (Armando et al., 2017). 
Adaptive functioning is an area that has been found to be impacted by internalizing and 
psychotic symptoms (Schneider et al., 2014). As expected in the general population, internalizing 
symptoms and psychotic symptoms can significantly impact an individual’s ability to adapt and 
navigate the demands placed on the individual by their environment (Schneider et al., 2014). 
Likewise, these symptoms can be even more impactful in the adaptive functioning of individuals 
with 22q11DS (Schneider et al., 2014). There is a need to discover how these factors can be 
controlled to allow individuals to develop and improve adaptive functioning (Schneider et al., 
2014). 
Another outcome that has been heavily studied concerning 22q11DS is the onset of 
psychosis and schizophrenia (Gothelf et al., 2007). The 22q11DS population has high rates of 
developing schizophrenia, and it has become a focal point of 22q11DS research to discover the 
connections between these disorders (Mekori-Domachevsky et al., 2017). One possible link 
between these disorders may be internalizing symptoms such as anxiety (Gothelf et al., 2007). 
Gothelf et al. (2007) found that there may be a link between internalizing symptoms and the 
onset of psychosis. They suggest that further study is needed to establish a link so that 
interventions can be developed to target these symptoms and prevent the onset of psychosis 
(Gothelf et al., 2007). 
Trajectory of Internalizing Symptoms in Individuals with 22q11DS 
 The trajectory of how internalizing symptoms change over time is an area of research that 
needs to be elucidated. There have been several studies that have identified the broad trajectories 
of psychiatric problems that may be tangential to 22q11DS (Kates et al., 2018; Wagner et al., 
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2017). In fact, a study conducted by Kates et al. (2018) has recently looked at how these 
psychiatric problems progress over the course of nine years in individuals with 22q11DS, while 
controlling for age, sex, IQ, SES, and diagnosis. They found that many of the psychiatric 
disorders that are prevalent in this population progress at much higher rates than previously 
expected. They found that 29% of their sample continued to experience ADHD at the final time 
point, and that anxiety disorders were relatively stable over time. They found that at time point 
one, 30% of their sample had an anxiety disorder and at time point 4 that number had risen 
slightly to 34%. They observed stable rates of depression across all four time points with the rate 
staying between 17%-19%. The most significant difference that they observed was in psychosis. 
They found that the rate of psychosis jumped from 9% to 24% of the sample from the first time 
point to the last. Due to their findings, they suggest that earlier interventions need to be 
implemented to prevent these psychiatric conditions from persisting (Kates et al., 2018). With 
the high prevalence rates and the progression of these symptoms, it is imperative to address 
anxiety and depression in this population earlier. 
Factors Affecting Trajectory of Internalizing Symptoms 
 Because the trajectory of these internalizing symptoms is still unknown, it is difficult to 
surmise what factors may directly influence them; however, with the use of the knowledge 
research has provided on how psychiatric disorders progress over time, a couple of factors can be 
hypothesized as being potential predictors of these trajectories (Kates et al., 2018). Cognitive 
symptoms of 22q11DS most likely play a role in how internalizing symptoms change over time 
(Swillen, Moss, & Duijff, 2018). Three cognitive factors that may play important role in these 
trajectories are intelligence, attention, and working memory (Jacobson et al., 2010; Montojo et 
al., 2014; Sanders, Hobbs, Stephenson, Laird, & Beaton, 2017).  
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 Intelligence. With 22q11DS being associated with lower IQ and intellectual disability, it 
is likely that intelligence plays a key role in the trajectory of internalizing symptoms (Fabbro et 
al., 2012). Several studies have found a link between intelligence and anxiety and depression, but 
there is a need for this relationship to be better understood (Fabbro et al., 2012; Hooper et al., 
2013; Tang et al., 2014). Because there is a link between these two variables, it is possible that 
intelligence somehow affects the trajectory of internalizing symptoms. These studies conclude 
that there is a need to discover what role intelligence plays in the onset and pathology of anxiety 
and depression in this population (Fabbro et al., 2012; Tang et al., 2014). 
 Attention. Another feature of 22q11DS that could likely affect the trajectory of 
internalizing symptoms is attention. Individuals with 22q11DS often meet criteria for ADHD as 
well as other psychiatric conditions (Niarchou et al., 2018). There have been many links found 
between attention and internalizing symptoms such as anxiety and depression (Antshel et al., 
2007), and Niarchou et al. (2018) have found that ADHD may even be related to the onset of 
psychotic features in these individuals. Attention may play a key role in mediating the 
relationship between anxiety and depression, and the subsequent onset of psychotic symptoms 
(Armando et al., 2017; Duijff et al., 2017; Niarchou et al., 2018). There is a need to explore how 
attention plays a role in these symptoms and how they can be properly addressed.  
 Working memory. Harrell et al. (2017) found that individuals with 22q11DS have clear 
and marked differences in working memory as compared to typically developing children. 
Montojo et al. (2013) found that there was a link between disrupted working memory circuitry 
and psychotic features. They expound that these working memory disruptions may be another 
factor that could be playing a role in the development of psychosis. Sanders et al. (2017) also 
reported that there was a clear link between working memory and anxiety in their sample. They 
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found that anxiety was affecting working memory. They suggest that the relationship may be 
bidirectional, but further research is needed to disentangle these findings (Sanders et al., 2017). 
Working memory may play a key role in the progression of symptoms of anxiety and depression 
which, in turn, may lead to the development of psychotic features (Montojo et al., 2013; Sanders 
et al., 2017)
 
 Demographics. Finally, it may be pertinent to explore how basic demographic 
differences affect internalizing symptoms over time. Fabbro et al. (2012) found that age related 
factors of cognition predicted differences in anxiety in the 22q11DS sample that they studied. 
They suggested that age may play a significant role in factors affecting the 22q11DS population. 
Likewise, other demographic information may also play a role and is in need of being explore 
further (e.g., gender, SES, race; Fabbro et al., 2012). For example, given the reported higher rates 
of affective disorders in females, particularly during adolescence, it remains important to see if 
gender plays a role in the presence and change of internalizing symptoms over time in 22q11DS.  
Prior Longitudinal Studies 
 Given that this paper is addressing the longitudinal trajectory of internalizing symptoms 
in 22q11DS, it becomes important to examine the few longitudinal studies that have been 
conducted with this population to date (Duijff et al., 2017; Hooper et al., 2013; Kates et al., 
2018; Mihailov et al., 2017; Radoeve et al., 2017; Ramanathan et al., 2017; Wagner et al., 2017). 
Many of these studies have looked at the trajectories of the symptoms associated with 22q11DS 
such as cognitive symptoms, behavioral symptoms, psychiatric diagnoses, social functioning, 
brain morphology, and symptoms of psychosis (Duijff et al., 2017; Kates et al., 2018; Mihailov 
et al., 2017; Radoeve et al., 2017; Ramanathan et al., 2017). Duijff et al. (2017) found that 
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internalizing symptoms—specifically withdrawal and depression—increased over time, and they 
suggested that these symptoms could be related to the development of negative symptoms of 
schizophrenia later in life (Duijff et al., 2017; Mihailov et al., 2017). Similarly, Kates et al. 
(2018) found that psychosis-spectrum disorders became more prevalent in their sample over 
time. They suggested that this increase, nearly 2.5-fold (9% to 22%) could be related to the 
development and persistence of internalizing symptoms in this population, and they 
recommended that further studies try to observe these trajectories in order to corroborate their 
hypothesis and prior findings (Kates et al., 2018). Hooper et al. (2013) found that psychiatric and 
psychotic symptoms increased in the population over time, while overall global functioning and 
neurocognition declined. They suggested that further studies need to observe the 
neuropsychiatric outcomes in individuals with 22q11DS in order to address the development of 
the psychiatric and psychotic symptoms (Hooper et al., 2013). Additionally, Wagner et al. (2017) 
found that social functioning declined over time and was likely affected by the increase in 
internalizing symptoms. They suggested that the social withdrawal and lower social functioning 
are likely related to prodromal symptoms of psychosis, but further research is required to 
substantiate this hypothesis (Wagner et al., 2017). 
Present Aims 
 There have been many studies conducted on the 22q11DS population and the various 
factors that affect their quality of life (Hooper et al., 2013; Kates et al., 2018; Mihailov et al., 
2017). However, there have not been many longitudinal studies in populations of 22q11DS, and 
even fewer that have specifically explored the longitudinal trajectories of internalizing symptoms 
in this population. The primary goal of this project is to discover how the trajectories of 
internalizing symptoms change in order to provide a better understanding of what individuals 
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with 22q11DS are experiencing over time. This better understanding will hopefully lead to 
targeted interventions at various time points to help these individuals cope with these 
internalizing symptoms and learn proper skills to manage them. It is also pertinent to explore 
what factors predict and affect these trajectories. If these factors can be isolated, interventions 
can be tailored to address these factors to maximize the outcomes of these interventions.  
Research Questions:
Question 1: How do internalizing symptoms change over time in the 22q11DS population? 
Hypothesis 1: It is hypothesized that, as time progresses, internalizing symptoms (i.e., anxiety, 
depression, withdrawal) will continue to worsen and become more prevalent in this population 
given stable characteristic such as race, ethnicity, and SES. Specifically, it is hypothesized that 
lower socioeconomic status, female gender, and older chronological age will have higher rates of 
internalizing symptoms. 
Question 2: What factors affect the trajectories of internalizing symptoms in the 22q11DS 
population? 
 Hypothesis 2: It is hypothesized that deficits in three distinct cognitive factors will affect these 
trajectories: intelligence, attention, and working memory. It is hypothesized that deficits in each 
of these areas will lead to poorer trajectories of internalizing symptoms in these individuals.  
Potential Implications for Rehabilitation Professionals 
 Answering these research questions will potentially have broad implications for 
rehabilitation professionals. It will potentially provide these professionals with better 
understanding of 22q11DS and how these individuals can benefit from rehabilitation counseling. 
It will provide these professionals information about the impact of internalizing symptoms and 
how they can target those symptoms to help these individuals. These findings will provide 
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rehabilitation professionals tangible information about what processes lead to poorer functioning 
in these individuals and how pertinent it is to be aware of these processes. 
 The potential findings of this study will provide rehabilitation professionals a timetable of 
when to best provide services for these individuals and when to implement certain interventions. 
This study will provide rehabilitation professionals a timeline of how symptoms progress in 
these individuals and how various factors affect those trajectories providing them with a general 
timeline of what they can expect of individuals with 22q11DS. Finally, this study will provide 
these individuals with information about what factors they will need to address if they work with 
















CHAPTER 2: METHODS 
Participants  
 Participants of the study consisted of 82 individuals who had been diagnosed with 
22q11DS and who had participated in several NIH-funded research projects at Duke University 
(see Data Use Agreement between Duke and UNC-CH). The participants ranged in chronological 
age from 7 to 18 years old. The participants were recruited from medical genetics clinics in 
North Carolina, but the majority were recruited from the Genetics Clinic at Duke University 
Medical Center. There are no significant age differences between the groups on chronological 
age, race/ethnicity, gender, and socioeconomic status as defined by maternal education at study 
entry. Please see Table 1 for a description of the sample at study entry, and the 3-year and 6-year 
follow-up time points respectively.  
Predictor Measures 
Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV; Wechsler, 
2003). The WISC-IV assesses the participants’ intelligence and working memory. The full-scale 
IQ (FSIQ) score was used to quantify the covariate of intelligence, and the working memory 
index (WMI) was used to quantify the covariate of working memory. Both scales have a mean of 
100 and a standard deviation of 15. Individuals who score under a 70 are denoted as having an 
intellectual disability. For overall IQ, the WISC-IV has excellent split-half reliability (r = .97) 
and test-retest reliability (r = .93; Wechsler, 2003). For working memory, the WISC-IV also has 
excellent split-half reliability (r = .92) and test-retest reliability (r = .89; Wechsler, 2003). The 
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measure maintains good concurrent validity with the WISC-III for overall IQ (r = .89) and 
working memory (r = .72; Wechsler, 2003).  
Continuous Performance Test Identical Pairs d-Prime and AX d-Prime (CPT-
IP/AX; Cornblatt, Risch, Faris, Friedman, & Erlenmeyer-Kimling, 1988). The CPT-IP/AX 
assesses various aspects of attention. It measures attention by using numbers and shapes and 
having a child attend to these numbers and shapes while they simultaneously must ignore 
distraction numbers and shapes. The distractions consist of both auditory and visual distractions. 
The CPT-IP/AX consists of 150 number trials and 150 shapes trials. Individuals are scored based 
on the number of correct hits in each trial. The CPT-IP/AX has a good test-retest reliability (r 
= .73) and it has been shown to be appropriate for use with children, adolescents, and adults 
(Cornblatt et al., 1988). The CPT-IP/AX has excellent face validity, but the actual ecological 
validity of the measure is still in question (Cornblatt et al., 1988). 
Demographic Variables. Chronological age was reported at the time of entry into the 
study; Race/ethnicity and gender are reported as described by the family and the participant; and 
socioeconomic status (SES) is calculated using Hollingshead Four-Factor Index.   
Outcome Measure 
Child Behavior Checklist (CBCL; Achenbach & Ruffle, 2000). The CBCL parent 
report rating scale that assesses the behavior of children. The CBCL was used to assess the 
various internalizing symptoms in the participants. For the purpose of this study, the individual 
participants overall internalizing behaviors T-score based on parent report will be used to 
quantify the variable of internalizing symptoms. This score is calculated by summing the 
anxious/depressed score, withdrawn-depressed score, and the somatic complaints score. The 
CBCL has moderately high internal consistency with the alphas ranging from .78 to .97 
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(Achenbach & Ruffle, 2000). The measure also has good concurrent validity for internalizing 
symptoms with the Behavior Assessment System for Children (r =.72-.89; Achenbach & Ruffle, 
2000).  
Procedures  
 The data were collected as a part of a larger study of 22q11DS conducted by Duke 
University Medical Center (Principal Investigator: Dr. Shashi). The study was funded by the 
National Institute of Mental Health. The larger study received IRB approval from Duke 
University and a data use agreement was completed to allow the data to be used cross-
institutionally. The data were gathered in the medical genetic clinic at Duke University and the 
affiliated centers. The data were de-identified and entered into an encrypted computer. The data 
were shared through the use of the cloud-based service, Dropbox, and are not stored or otherwise 
available on any other hard drive. The data were accessed through a secure computer in a secure 
location for analysis. The data were analyzed to answer the questions of this study.  
Statistical Analysis  
Research Question 1: How do internalizing symptoms change over time in the 22q11DS 
population?  
To answer this question, Mplus Statistical Software was used to conduct a two-level 
multilevel longitudinal analysis (Muthén & Muthén, 2017). The trajectory of each participant 
was observed, and a longitudinal curve was created to show the overall trajectory of the 
participants while taking into account the three demographic variables (i.e., ethnicity, gender, and 
SES) assessed in this study. The analysis incorporated three time points to generate a multilevel 
growth curve model: baseline, 3-year follow-up, 6-year follow-up. 
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Research Question 2: What factors affect the change occurring in the trajectories of 
internalizing symptoms in the 22q11DS population?  
To answer this question, Mplus statistical software was used to conduct a two-level 
multilevel longitudinal analysis that incorporate the time-carrying covariates from their first 
available assessment (i.e. attention, working memory, intelligence) to their last. The analyses 
incorporated all three time points mentioned above, and the analyses determined how these 
covariates affected the trajectory of internalizing symptoms in each participant. A multilevel 
growth curve model was generated to observe the overall statistical effect of these covariates.  
 Multilevel modeling (MLM) is favorable compared to other approaches because it 
accounts for data that utilizes repeated measurement occasions that are nested within each 
participant (Singer and Willet, 2003). It allows for the modeling of both random and fixed effects 
that allow individual and group differences over time to both be included in the model. This 
allows there to be more flexibility in the data while also taking into account individual cases with 











CHAPTER 3: RESULTS 
 A two-level random slope model was used to conduct the initial analysis (see Table 2). 
The level 1 units were the three time points of measurement, nested within the 83 individuals 
(level 2 units) in the study. Initial analysis included the modeling of the development of 
internalizing scores over time using the measurement of age at assessment as a predictor. Time 
was centered at age 18; therefore, the three timepoints are represented by -11 (age 7), -5.5 (age 
12.5), and 0 (age 18; see Figures 1-4).  
Initial exploratory analysis showed that at an individual or within level, internalizing 
symptoms were found to have significant variances on time ( = 42.142, p < .001), but the 
variance of the slope of time at the between level was not found to be statistically significant ( 
= .291, p = .431). Thus, a second model was analyzed with this slope constrained to allow for the 
other variables to be less dependent on the slope of the trajectory (see Table 3). In this model, the 
variance of the internalizing symptoms remained statistically significant ( = 44.003, p < .001). 
Sex, ethnicity, and SES were each found to have statistically significant slope and intercept 
within the model. Specifically, majority status and lower SES predicted higher internalizing 
symptoms as time progressed and being male predicted lower internalizing symptoms as time 
progressed (see Figures 1, 2 and, 3). Males were found to have higher internalizing scores at both 
the first and second timepoints, but they subsequently improved at a larger rate than their female 
counterparts. Due to the low number of individuals who identified as an ethnic minority, these 
individuals were all analyzed together and compared to the ethnic majority. If sex, ethnicity, and 
SES are held constant, the trajectory of internalizing symptoms improved over time (see Figure 
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4). Specifically, the projected internalizing symptoms t-score jumped from 75 to 50 from 
timepoint 1 to timepoint 3.   
 A similar model was conducted for the cognitive feature of 22q11DS. The model found 
that the data could not converge allowing the accurate calculation of the trajectory given that 
these features are included in the model as level 1 predictors. Constrained models were 
conducted afterwards to determine if these features have individual effects on the trajectory on 
internalizing symptoms, but all models could not converge without constraints places on the 
individual cognitive factors. Individual models for each cognitive feature were created to see if 
individual effects could be found. The earliest models that could converge for each feature can be 
seen in Tables 4, 5 and 6. Each model found that the cognitive features involved with 22q11DS 














CHAPTER 4: DISCUSSION 
 The aim of the present study was to observe the longitudinal trajectories of internalizing 
symptoms in individuals with 22q11DS and how constant and time-varying covariates impacted 
these trajectories. Prior studies have not looked at the longitudinal trajectories of these 
internalizing symptoms in the 22q11DS population, and very few studies in general have 
observed any sort of longitudinal data within this population (Duijff et al., 2017; Hooper et al., 
2013; Kates et al., 2018; Mihailov et al., 2017). Prior studies have found that these internalizing 
symptoms are highly prevalent in this population and impact these individuals in both individual 
and social functioning (Duijff et al., 2017; Mihailov et al., 2017; Wagner et al., 2017). Thus, it 
was hypothesized that these trajectories would increase in this population; however, the opposite 
was found. The trajectory of internalizing symptoms improved when controlling for 
demographic variables and when allowing the interactions of these variables. This finding could 
perhaps be explained by the individuals learning to adapt to their symptoms and learning to 
manage them better as they age. Also, this finding could be explained by the general trajectory 
internalizing symptoms in typical individuals. In typically developing children internalizing 
symptoms typically improve as time progresses (Weeks et al., 2014; Wetter & El-Sheikh, 2012). 
This finding may suggest that individuals with 22q11DS may not differ entirely when compared 
to typically developing individuals who have high internalizing symptoms.  
 As hypothesized, females and individuals from lower SES backgrounds had higher 
prevalence of internalizing symptoms. Interestingly, males had higher severity of internalizing 
symptoms at the first and second timepoint before improving more rapidly than their female 
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counterparts. This finding could be potentially be explained by males with developmental 
disabilities feeling isolated and having poorer adaptive skills when compared to female 
individuals (Rieffe et al., 2011). Similar to other developmental populations such as autism, it is 
possible that male individuals with 22q11DS have difficulty regulating these internalizing 
symptoms and are more likely to feel isolated at younger ages, but as time progresses and these 
individuals begin to cope with their symptoms, they begin to progress faster than their female 
counterparts (Rieffe et al., 2011). As with the typically developing population, adolescent 
females exhibit more internalizing symptoms (Reynolds & Juvonen, 2011). Consistent with both 
my hypothesis and the literature, individuals from lower SES backgrounds exhibited more severe 
internalizing even though both improved over time (Mendelson, Kubzansky, Datta, & Buka, 
2008; Ursache, Merz, Melvin, Meyer, & Noble, 2017).  
 Interestingly, individuals from a majority or Caucasian background had more 
internalizing symptoms than individuals from an ethnic minority background. This finding is the 
opposite effect that I had hypothesized. This finding could be due to the lack of ethnic diversity 
in the sample. However, these findings could suggest that there may be factors associated with 
majority status that lead individuals with 22qllDS to exhibit more severe internalizing symptoms 
when compared to their minority counterparts. This perhaps could be explained by cultural 
differences such as the importance of individualism compared to collectivism. Perhaps, the 
individuals from a minority background were more enmeshed with their culture and individuals 
in that culture leading to less internalizing issues; whereas, the majority individuals may see the 
importance of individualism in their culture and feel as though they are unable to meet that 
cultural norm leading to more internalizing issues.  
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 Intelligence, working memory, and attention were found to have no effect on 
internalizing symptoms. The models observing these relationships were heavily constrained due 
to the data, and the results could be heavily impacted due to these constraints. However, when 
the models did converge, they found that there are no observable effects due to the cognitive 
symptoms associated with 22q11DS. These findings suggest that the common features associated 
with 22q11DS do not play a role in the progression of internalizing symptoms. This outcome 
suggests that there might be other factors that lead to the development of internalizing 
symptoms. Though prior studies suggest that factor such as intelligence, working memory, and 
attention affect specific internalizing symptoms such as anxiety, depression, and withdrawal, the 
findings of this study suggests that these factors play no role in the trajectory of these symptoms 
(Jacobson et al., 2010; Montojo et al., 2014; Sanders, Hobbs, Stephenson, Laird, & Beaton, 
2017). There is a possibility that the initial onset of these internalizing symptoms could be 
explained by the cognitive symptoms of 22q11DS, but further research will need to be done in 
order to confirm if these features play a role in the trajectory of these internalizing symptoms. 
Implications for Rehabilitation Counselors  
 The findings of this study have both broad and specific implications for rehabilitation 
counselors and professionals. Though the trajectories of these individuals improved over time, 
the findings of this study show that there are high amounts of internalizing symptoms in this 
population at a young age. Rehabilitation counselors can work to ensure that these individual’s 
disability does not affect their personal, social, and educational development. It is the job of a 
rehabilitation counselor to help minimize the impact of a disability on an individual, and 
rehabilitation counselors can work to address these internalizing symptoms at the early stages of 
their development. Though they do not seem to progress given the results of this study, 
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internalizing symptoms are something that can be debilitating at any age and addressing them in 
these young individuals will surely lead to better outcomes. 
 Another implication for rehabilitation counselors is to be aware of the role sex, ethnicity, 
and SES specifically play in these individuals. This study found unique effects and interactions 
with each of these factors and internalizing symptoms. It will be important for rehabilitation 
counselors to think about these interactions when working with these individuals. Though a 
rehabilitation counselor will likely already consider these demographic variables, it will be 
important for them to know the specific interactions found in this study to be able to maximize 
the rehabilitation potential of these individuals. Rehabilitation counselors will need to be mindful 
of these findings and be sure to assess internalizing symptoms more directly in individuals from 
lower SES backgrounds, majority or non-minority individuals, and male children and female 
adolescents.  
 A broader implication for rehabilitation counselors is to consider the role the symptoms 
of 22q11DS play in the disability of these individuals. Though this study did not find any 
interaction of the cognitive symptoms of 22q11DS and internalizing symptoms, these symptoms 
still deeply impact the lives of these individuals (Campbell et al., 2010; Niarchou et al., 2015). It 
will be important for rehabilitation counselors to keep in mind the distinct effects of these 
features and internalizing symptoms as found by this study. Internalizing issues are still a 
problem in this population, and it will important for rehabilitation counselors to address these 
issues. To be able to best work with these individuals, it will be important for rehabilitation 
counselors to know that they will need to address both of these issues to successfully help with 
the rehabilitation of these individuals.  
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 It will also be important for rehabilitation counselors to consider how these internalizing 
symptoms affect employment and community participation. Prior studies have found that 
internalizing symptoms can often significantly affect employment outcomes, schooling 
outcomes, and social function (Armando et al., 2017; Kikinis et al., 2017; Schneider et al., 2017). 
It will be important for rehabilitation counselors to know that they can assist with these outcomes 
by addressing these symptoms. Though this study found that internalizing symptoms improved 
in this population, individuals at transition age still face significant internalizing issues that can 
affect school, work, and community participation. Knowing the trajectories of the internalizing 
symptoms will allow for rehabilitation and mental health counselors to provide timely 
interventions that will help improve these various outcomes by addressing these internalizing 
issues. The findings of this study inform rehabilitation counselors of the severity of internalizing 
symptoms at earlier ages and provides them with an empirical basis of when to address these 
symptoms in these individuals  
Limitations  
 The sample lacked ethnic diversity and did not allow for analysis of differences between 
the individual ethnicities present in the study. Additionally, there were high amounts of missing 
data that did not allow for the initial models to converge. There is also the possibility that the 
results could have been different given more robust and complete data. Another possible 
limitation is the use of the CBCL to measure internalizing symptoms. Though the measurement 
has good psychometric properties, it is arguable that a parent may not be as accurately able to 
distinguish these internalizing symptoms as these individuals age. Though it is unlikely that this 
is the case, it will be important for future studies to implement further measures to either 
corroborate or contradict the results produced in this study.  
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Conclusion  
 The present study found that internalizing trajectories in individuals with 22q11DS 
improved as the individuals aged, counter to what was initially hypothesized. Sex, ethnicity, and 
SES were found to have significant effects in the trajectory of internalizing symptoms, 
suggesting that individuals who are female, identify as an ethnic majority, and/or from a low SES 
background have poorer outcomes than their counterparts. These findings suggest that 
individuals that work with the 22q11DS population will need to keep these factors in mind. The 
cognitive features of 22q11DS—intelligence, working memory, and attention—were found to 
have no significant effects on the trajectories of internalizing symptoms. Again, this was not the 
hypothesized outcome, but this outcome could perhaps be explained by the limitations of the 
data and the constraints that needed to be placed for the model to converge. Future studies will 
need to further elucidate the relationship between these symptoms and their effect on 
internalizing symptoms to effectively help these individuals in treatment settings. It is 
recommended that future studies build upon the findings of this study, address the limitations of 
this study, and further determine the effect of internalizing symptoms in the lives of individuals 









APPENDIX 1: TABLES 
Table 1. 
Sample Descriptives   
Characteristics T1 (n = 82) T2 (n = 53) T3 (n = 16) 
Age, years mean (SD) 11 (2) 14 (2) 16 (2) 
    
Gender:    
   Female, n (%) 37 (45%) 22 (42%) 4 (25%) 
   Male, n (%) 45 (55%) 31 (58%) 12 (75%) 
    
Ethnicity:    
   Caucasian  68 (83%) 46 (86%) 15 (94%) 
   African American 4 (5%) 1 (2%) 1 (6%) 
   Hispanic 5 (6%) 4 (8%) 0 
   Native American 1 (1%) 1 (2%) 0 
   Asian 1 (1%) 0 0 
   Biracial 
 

























Internalizing Symptoms Multilevel Model 
 Estimate S.E. t-ratio 2-Tail P-Value 
Within Level     
    Residual Variances     
        Internalizing Symptoms  42.142 8.048 5.236     0.000*** 
     
Between Level     
    Time     
        Ethnicity  1.925 0.815 2.363 0.018* 
        Sex -1.003 0.458 -2.187 0.029* 
        SES  0.038 0.017 2.203 0.028* 
     
    Internalizing Symptoms     
        Ethnicity 13.250 5.257 2.520 0.012* 
        Sex -3.916 2.822 -1.388        0.165 
        SES  0.224 0.107 2.102 0.036* 
     
    Intercepts     
      Internalizing Symptoms 42.393 7.376 5.747     0.000*** 
      Time -2.563 1.097 -2.336 0.019* 
     
    Residual Variances     
      Internalizing Symptoms 55.594 20.641 2.693     0.007** 
      Time   0.291   0.370 0.787 0.431 











Table 3  
Internalizing Symptoms Multilevel Model with Constrained Time 
 Estimate S.E. t-ratio 2-Tail P-Value 
Within Level     
    Residual Variances     
        Internalizing Symptoms 44.003 7.994 5.505      0.000*** 
     
Between Level     
    Time     
        Ethnicity 1.889 0.798 2.368   0.018* 
        Sex -1.028 0.473 -2.173   0.030* 
        SES 0.033 0.015 2.174   0.030* 
     
    Internalizing Symptoms     
        Ethnicity 12.862 5.162 2.492   0.013* 
        Sex -4.110 2.772 -1.483 0.138 
        SES 0.197 0.097 2.024   0.043* 
     
    Intercepts     
      Internalizing Symptoms 43.794 7.018 6.240       0.000*** 
      Time -2.343 1.039 -2.256   0.024* 
     
    Residual Variances     
      Internalizing Symptoms 67.454 14.648     4.605         0.000*** 
      Time 0.000 0.000 999.000      999.000 












Internalizing Symptoms Multilevel Model with Intelligence  
 Estimate S.E. t-ratio 2-Tail P-Value 
Within Level     
    Residual Variances     
        Internalizing Symptoms 42.566 8.427 5.051      0.000*** 
     
Between Level     
    Time     
        Ethnicity 2.107 0.762  2.764       0.006** 
        Sex    -0.857 0.498 -1.721   0.085 
        SES 0.034 0.015  2.319     0.020* 
     
    Intelligence      
        Ethnicity -0.182  0.102      -1.781             0.075 
        Sex -0.085 0.115 -0.737   0.461 
        SES -0.006 0.003 -1.841   0.066 
     
    Time x Intelligence      
        (iii) Ethnicity 0.000 0.000 999.000      999.000 
        (iii) Sex 0.000 0.000 999.000      999.000 
        (iii) SES 0.000 0.000 999.000      999.000 
     
    Internalizing Symptoms     
        Ethnicity 28.374 10.007 2.835     0.005** 
        Sex 3.510 9.819 0.357 0.721 
        SES 0.625 0.248 2.524   0.012* 
     
    Internalizing Symptoms     
        (ii) Time 0.000 0.000 999.000     999.000 
        (ii) Intelligence  0.000 0.000 999.000     999.000 
     
    Intercepts     
      Internalizing Symptoms 30.221 14.318  2.111   0.035* 
      Time -0.662   1.964 -0.337         0.736 
      Intelligence       0.149         0.155       0.959       0.338 
      Time x Intelligence      -0.027         0.023      -1.178       0.239 
     
    Residual Variances     
      Internalizing Symptoms 67.454 14.648     4.605      0.000*** 
      (i) Time 0.000 0.000 999.000    999.000 
      (i) Intelligence  0.000 0.000 999.000    999.000 
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      (i) Time x Intelligence  0.000 0.000 999.000    999.000 
Note: *p < .05, ** p < .01, ***p < .001; S.E. = Standard Error; Roman numerals represent the 
























Internalizing Symptoms Multilevel Model with Working Memory 
 Estimate S.E. t-ratio 2-Tail P-Value 
Within Level     
    Residual Variances     
        Internalizing Symptoms 43.378 9.057 4.789      0.000*** 
     
Between Level     
    Time     
        Ethnicity 1.999 0.773  2.586   0.010* 
        Sex    -0.858 0.485 -1.770         0.077 
        SES 0.037 0.018  2.007   0.045* 
     
    Working Memory     
        Ethnicity -0.131  0.119      -1.100            0.271 
        Sex -0.065 0.114 -0.564         0.572 
        SES -0.001 0.004 -0.372         0.710 
     
    Time x Working Memory     
        (iii) Ethnicity 0.000 0.000 999.000      999.000 
        (iii) Sex 0.000 0.000 999.000      999.000 
        (iii) SES 0.000 0.000 999.000      999.000 
     
    Internalizing Symptoms     
        Ethnicity 24.934 11.740 2.124   0.034* 
        Sex   2.571 10.777 0.239 0.811 
        SES   0.322 0.321 1.004 0.315 
     
    Internalizing Symptoms     
        (ii) Time 0.000 0.000 999.000     999.000 
        (ii) Working Memory  0.000 0.000 999.000     999.000 
     
    Intercepts     
      Internalizing Symptoms 37.906 16.175       2.344         0.019* 
      Time -1.368       1.737 -0.787         0.431 
      Working Memory      0.039       0.163       0.240       0.810 
      Time x Working Memory     -0.016       0.016      -1.016       0.310 
     
    Residual Variances     
      Internalizing Symptoms 39.365 18.071     2.178  0.029* 
      (i) Time 0.000 0.000 999.000    999.000 
      (i) Working Memory 0.000 0.000 999.000    999.000 
31 
      (i) Time x Working Memory 0.000 0.000 999.000    999.000 
Note: *p < .05, ** p < .01, ***p < .001; S.E. = Standard Error; Roman numerals represent the 























Table 6  
Internalizing Symptoms Multilevel Model with Attention 
 Estimate S.E. t-ratio 2-Tail P-Value 
Within Level     
    Residual Variances     
        Internalizing Symptoms 27.736 5.850 4.741      0.000*** 
     
Between Level     
    Time     
        Ethnicity 2.105 0.473 4.262         0.000*** 
        Sex    -0.560 0.435 -1.287   0.198 
        SES 0.028 0.011  2.507     0.012* 
     
    Attention     
        Ethnicity  0.171  0.165       1.036             0.300 
        Sex  0.169    0.181  0.934   0.350 
        SES -0.007 0.006 -1.124   0.261 
     
    Time x Attention      
        (iii) Ethnicity 0.000 0.000 999.000      999.000 
        (iii) Sex 0.000 0.000 999.000      999.000 
        (iii) SES 0.000 0.000 999.000      999.000 
     
    Internalizing Symptoms     
        Ethnicity 3.720 11.077 0.336 0.737 
        Sex  -10.935 12.302  -0.889 0.374 
        SES 0.557 0.395 1.412 0.158 
     
    Internalizing Symptoms     
        (ii) Time 0.000 0.000 999.000     999.000 
        (ii) Attention  0.000 0.000 999.000     999.000 
     
    Intercepts     
      Internalizing Symptoms -2.957      20.577      -0.144        0.886 
      Time -4.022       1.635      -2.460              0.014* 
      Attention       0.743       0.301        2.470         0.014* 
      Time x Attention      0.029       0.023      1.259       0.208 
     
    Residual Variances     
      Internalizing Symptoms 39.645      11.082         3.577            0.000*** 
      (i) Time 0.000 0.000 999.000    999.000 
      (i) Intelligence  0.000 0.000 999.000    999.000 
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      (i) Time x Attention 0.000 0.000 999.000    999.000 
Note: *p < .05, ** p < .01, ***p < .001; S.E. = Standard Error; Roman numerals represent the 
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